← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2004Last known activity
Oct 1, 2014
Timeline
1920s
- Jun 1, 1929
Hiroshima University— Founded
Drugs by trial phase (20 distinct, 15 trials)
Phase 3 (1 own, 0 via acquisition)
Other trials (19 own, 0 via acquisition)
Indications
Studied for
Recent trials (35)
- NCT02300181Lead sponsorN/AOct 1, 2014
- NCT02300181Overall official - principal investigatorN/AOct 1, 2014
- NCT02300181Reponsible party - principal investigatorN/AOct 1, 2014
- NCT02213549Lead sponsorN/AJul 1, 2014
- NCT02213562Lead sponsorN/AJul 1, 2014
- NCT02213562Reponsible party - principal investigatorN/AJul 1, 2014
- NCT02213549Reponsible party - principal investigatorN/AJul 1, 2014
- NCT02213562Overall official - principal investigatorN/AJul 1, 2014
- NCT02213549Overall official - principal investigatorN/AJul 1, 2014
- NCT02050555Reponsible party - principal investigatorN/ADec 1, 2013
- NCT02050555Overall official - principal investigatorN/ADec 1, 2013
- NCT02050555Lead sponsorN/ADec 1, 2013
- NCT02023320Lead sponsorN/ANov 1, 2013
- NCT02019368Lead sponsorN/ANov 1, 2013
- NCT02019368Reponsible party - principal investigatorN/ANov 1, 2013
Details
- Founded
- Hiroshima, JP Jun 1, 1929
- Last known activity
- Oct 1, 2014